BTIG analyst Marie Thibault raised the firm’s price target on iRhythm (IRTC) to $135 from $120 and keeps a Buy rating on the shares after its ...

In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price ...

Virtual Meeting to be held on February 20 hosted by BTIG. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

Digital Services Analyst Fuller holds a meeting with management in Boston on February 24 hosted by BTIG. Published first on TheFly – the ultimate ...

When we spoke three years ago, your research was focused on the shopping center, net lease and health care subsectors. Is there anything new or different about your coverage universe here in 2025? Mr.

Investing.com -- BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain disruptions that could hamper growth in 2025. The brokerage ...

BTIG Research decreased their Q1 2025 earnings estimates for shares of Meritage Homes in a report issued on Tuesday, February ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

As of December 23, 2024, the average one-year price target for ImmunityBio is $14.54/share. The forecasts range from a low of $4.80 to a high of $31.50. The average price target represents an ...

Am Dienstag hat BTIG-Analyst David Larsen das Kursziel für Hims & Hers Health (NYSE: HIMS) deutlich angehoben. Das neue Ziel liegt bei 85,00 US-Dollar, was einen erheblichen Anstieg gegenüber dem vorh ...

Am Mittwoch revidierte BTIG-Analyst Marvin Fong das Kursziel für die Etsy-Aktie (NASDAQ: ETSY) von 65 auf 60 US-Dollar nach unten, empfiehlt aber weiterhin den Kauf. Fongs Analyse folgte auf Etsys Ber ...